Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: A new majpker for predicting disease progression

British Journal of Urology

Volumn 77, Issue 1, 1996, Pages 96-101

  Shiina, H ^a   Igawa, M ^a   Ishibe, T ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Dihydrotestosterone; Estramustine binding protein; Human prostatic carcinoma; Progression; Prostate specific antigen; Zinc

Indexed keywords

ESTRAMUSTINE; ESTRAMUSTINE BINDING PROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; ZINC;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; DIHYDROTESTOSTERONE; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030031207     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.81516.x     Document Type: Article

References (27)

1. Mittelman A, Catane R, Murphy GP. New steroidal alkylating agents in advanced stage D carcinoma of the prostate. Cancer Treat Rep 1977; 61: 307-10
2. Johnson G, Högberg B. Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report. Scand J Urol Nephrol 1971; 5: 103-7
3. 3H-estramustine in the rat ventral prostate. Acta Pharmacol Toxicol 1979; 43: 368-74
4. Försgren B, Gustafsson J-Å, Pousette Å. Högberg B. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of estradiol-17b. Cancer Res 1979; 39: 5155-64
5. Heisaeter PA, Kadohama N. Corrales JJ, Karr JP, Murphy GP, Sandberg AA. Characterization of androgen receptor and estramustine binding protein of rat ventral prostatic tissue in organ culture. J Steroid Biochem 1981 ; 14: 2 51-60
6. Försgren B, Björk P, Carlström K, Gustafsson J-̊, Högberg B . Purification and distribution of a major protein in the rat prostate that binds estramustine: a nitrogen mustard derivative of estradiol-17. Proc Natl Acad Sci USA 1979; 76: 3149-53
7. Björk P, Försgren B, Gustafsson J-Å, Högberg B. Partial characterization and 'quantitation' of a human prostatic estramustine-binding protein. Cancer Res 1982; 42: 1935-42
8. Shiina H, Ishibe T, Usui T. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA. Biochem Biophys Res Commun 1989; 165: 947-55
9. Pousette Å, Björk P. Carlström K. Försgren B, Högberg B. Gustafsson J-Å. Influence of sex hormones on prostatic secretion protein, a major protein in rat prostate. Cancer Res 1981; 41: 688-90
10. de laTorre M, Eklöv S, Häggman M, Björk P, Busch C, Nilsson. S. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia. Prostate 1994; 25: 125-31
11. Flüchter SH, Neide HJ. Björk P, Müntzing J. Bichler K-H. Effect of treatment on the 'expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study. Prostate 1989; 14: 27-43
12. Goldfarb DA. Stein BS, Shamszadeh M, Peterson RO. Age-related changes in tissue levels of prostatic acid phosphatase and prostate specific antigen. J Urol 1986; 136: 1266-9
13. Grignon D, Troster M. Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbesterol therapy. Prostate 1985; 7: 195-202
14. Giels PJ, Cousins RJ. Hormonal regulation of zinc metabolism in a human prostatic carcinoma cell line (PC-3). Cancer Res 1982; 42: 2-7
15. Geller J. Liu J, Albert JD. Fay W, Berry CC, Weis P. Relationship between human prostatic epithelial cell protein synthesis and tissue dihydrotestosterone level. Clinical Endocrinol 1987; 26: 155-61
16. Geller J, Albert JD. DHT in prostate cancer tissue: a guide to management and therapy. Prostate 1985; 6: 19-25
17. Shiina H, Sumi H, Ishibe T, Usui T. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue. Ural Int 1994; 52: 213-6
18. Catalona WJ, Scott WW. Carcinoma of the prostate. J Urol 1978; 119: 7-8
19. Györkey F, Min KW. Huff JA, Györkey P. Zinc and magnesium in human prostate gland: normal, hyperplastic and neoplastic. Cancer Res 1967; 27: 1348-53
20. Shiina H, Ishibe T, Usui T. Immunoreactive protein to rat estramustine binding protein in human seminal plasma: its relationship to prostatic acid phosphatase and zinc. Andrologia 1991:23: 177-9
21. Shiina H. Mizutani M, Ishihe T. Estramustine binding protein in human benign prostatic hypertrophy. Andrologia 1990: 22: 509-12
22. Eklöv S. Larson A, Björk P, Nilsson S. The expression of estramustine-binding protein in the human prostalie cancer cell line Dl 145 is not androgen dependent. Scand J Urol Nephrol 1992: 26: 1 19-25
23. Tribukait 15, Rönström L. lisposti PL. Quantitative and qualitative aspects of How DNA measurements related to the cytologie grade in prostatic carcinoma. Anal Quant Cytol 1985: S: 107-11
24. Erankl'urt OS. Chin JL, Engländer LS. Greco WR. Pontes JE. Rustum YM. Relationship between DNA ploidy. glandular differentiation, and tumor spread in human prostate cancer. Cam er Res 1985: 45: 1418-25
25. Lundberg S. Carstensen J. Rundquist I. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Gimrr Res 1987: 47: 1973-77
26. Norlén B|. Andersson SB. Björk P. Gunnarsson PO. Friljofsson A. Uptake of estrumustine phosphate metabolites in prostatic cancer. J Urol 1988: 140: 1058-62
27. Kokontis J. Ito K. Hiipakka RA. Liao S. Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation. Receptor 1991: 1: 271-9